blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3581202

EP3581202 - COMPOSITION AND METHOD FOR STABILISING VACCINES IN A SOLID DOSAGE FORMAT [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  30.10.2020
Database last updated on 03.01.2025
FormerThe application has been published
Status updated on  15.11.2019
Most recent event   Tooltip30.10.2020Application deemed to be withdrawnpublished on 02.12.2020  [2020/49]
Applicant(s)For all designated states
University College Cork-National University of Ireland, Cork
College Road
Cork / IE
[2019/51]
Inventor(s)01 / Donadei, Agnese
University College Cork - National University of
Ireland, Cork, School of Pharmacy
College Road
Cork / IE
02 / Flynn, Olivia
University College Cork - National University of
Ireland, Cork, School of Pharmacy
College Road
Cork / IE
03 / Moore, Anne
University College Cork - National University of
Ireland, Cork, School of Pharmacy
College Road
Cork / IE
 [2019/51]
Representative(s)Murgitroyd & Company
Murgitroyd House
165-169 Scotland Street
Glasgow G5 8PL / GB
[N/P]
Former [2019/51]Murgitroyd & Company
Scotland House
165-169 Scotland Street
Glasgow G5 8PL / GB
Application number, filing date18177686.514.06.2018
[2019/51]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3581202
Date:18.12.2019
Language:EN
[2019/51]
Search report(s)(Supplementary) European search report - dispatched on:EP02.10.2018
ClassificationIPC:A61K39/12, A61K9/00, A61K38/06, A61K31/00, A61K31/047, A61K31/198, A61K31/7016, C08L29/04
[2019/51]
CPC:
A61K39/12 (EP); A61K39/13 (US); A61K31/00 (EP);
A61K31/047 (EP); A61K31/198 (EP); A61K31/7016 (EP);
A61K38/063 (EP); A61K39/235 (US); A61K9/0021 (EP);
A61P31/12 (EP); C08L29/04 (EP); A61K2039/525 (EP);
A61K2039/55583 (US); A61K2039/6093 (US); A61K2800/52 (EP);
C12N2710/10034 (EP); C12N2770/32634 (EP); Y02A50/30 (EP) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2019/51]
Extension statesBANot yet paid
MENot yet paid
Validation statesKHNot yet paid
MANot yet paid
MDNot yet paid
TNNot yet paid
TitleGerman:ZUSAMMENSETZUNG UND VERFAHREN ZUR STABILISIERUNG VON IMPFSTOFFEN IN FESTEM DOSIERUNGSFORMAT[2019/51]
English:COMPOSITION AND METHOD FOR STABILISING VACCINES IN A SOLID DOSAGE FORMAT[2019/51]
French:COMPOSITION ET PROCÉDÉ DE STABILISATION DE VACCINS DANS UN FORMAT DE DOSAGE SOLIDE[2019/51]
Examination procedure19.06.2020Application deemed to be withdrawn, date of legal effect  [2020/49]
09.07.2020Despatch of communication that the application is deemed to be withdrawn, reason: examination fee not paid in time  [2020/49]
Fees paidPenalty fee
Additional fee for renewal fee
30.06.202003   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[I]FR2960781  (SANOFI PASTEUR [FR]) [I] 1-15 * pages 10-13; table 1 *;
 [I]  - GAURAV KANOJIA ET AL, "Developments in the formulation and delivery of spray dried vaccines", HUMAN VACCINES AND IMMUNOTHERAPEUTICS, US, (20170919), vol. 13, no. 10, doi:10.1080/21645515.2017.1356952, ISSN 2164-5515, pages 2364 - 2378, XP055507852 [I] 1-15 * pages 2367-237 *

DOI:   http://dx.doi.org/10.1080/21645515.2017.1356952
 [I]  - CHRIS EDENS ET AL, "Inactivated polio vaccination using a microneedle patch is immunogenic in the rhesus macaque", VACCINE, AMSTERDAM, NL, (20150901), vol. 33, no. 37, doi:10.1016/j.vaccine.2015.01.089, ISSN 0264-410X, pages 4683 - 4690, XP055507862 [I] 1-15 * Material and Methods, Results, Discussion *

DOI:   http://dx.doi.org/10.1016/j.vaccine.2015.01.089
 [I]  - KOEN VAN DER MAADEN ET AL, "Layer-by-Layer Assembly of Inactivated Poliovirus and N -Trimethyl Chitosan on pH-Sensitive Microneedles for Dermal Vaccination", LANGMUIR, US, (20150727), vol. 31, no. 31, doi:10.1021/acs.langmuir.5b01262, ISSN 0743-7463, pages 8654 - 8660, XP055507866 [I] 1-15 * abstract *

DOI:   http://dx.doi.org/10.1021/acs.langmuir.5b01262
 [I]  - F.-S. QUAN ET AL, "Intradermal Vaccination with Influenza Virus-Like Particles by Using Microneedles Induces Protection Superior to That with Intramuscular Immunization", JOURNAL OF VIROLOGY, (20100801), vol. 84, no. 15, doi:10.1128/JVI.01849-09, ISSN 0022-538X, pages 7760 - 7769, XP055080928 [I] 1-15 * Material and Methods *

DOI:   http://dx.doi.org/10.1128/JVI.01849-09
 [I]  - YING WAN ET AL, "Development of Stabilizing Formulations of a Trivalent Inactivated Poliovirus Vaccine in a Dried State for Delivery in the Nanopatch(TM) Microprojection Array", JOURNAL OF PHARMACEUTICAL SCIENCES, US, (20180206), vol. 107, no. 6, doi:10.1016/j.xphs.2018.01.027, ISSN 0022-3549, pages 1540 - 1551, XP055508192 [I] 1-15 * the whole document * * In particular, the figures. *

DOI:   http://dx.doi.org/10.1016/j.xphs.2018.01.027
 [I]  - Ying Wan ET AL, "Development of Stabilizing Formulations of a Trivalent Inactivated Poliovirus Vaccine in a Dried State for Delivery in the NanopatchTM Microprojection Array - Supplementary Data", Journal of Pharmaceutical Sciences, (20180206), URL: https://www.sciencedirect.com/science/article/pii/S0022354918300716?via%3Dihub#appsec1, (20180919), XP055508190 [I] 1-15 * the whole document *
by applicant   - J.C. MAY et al., "Measurement of final container residual moisture in freeze-dried biological products", Dev. Biol. Stand., (19920000), vol. 74, pages 153 - 164
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.